Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.
Identifying high-risk groups for pancreatic cancer (PC) may lead to earlier detection. We determined the risk of subsequent PC among survivors of sporadic colorectal cancer (CRC).



We evaluated data from the US Surveillance, Epidemiology, and End Results registry to identify individuals with primary CRC between the years 1973-2006. Standardized incidence ratios (SIRs) and 95 % confidence interval (95 % CI) were calculated to compare the risk of subsequent primary PC in the study cohort to that of the standard population. Analysis was stratified by age at diagnosis of CRC and sex. CRC characteristics were compared among CRC survivors with and without PC. Multivariate sub-hazard ratios were calculated to identify factors associated with subsequent primary PC, using death from non-PC causes as a competing event.



Of the 273,144 patients with first primary CRC, 657 (0.24 %) developed subsequent PC. CRC survivors were more likely to develop PC (SIR 1.22; 95 % CI 1.09-1.35). Mean latency period (time between CRC and PC diagnosis) was 1, 3, and 5 years from index age of CRC 20-49, 50-64, and >65 years, respectively. Multivariate analysis showed CRC survivors >50 years had 3.5-fold, those with right-sided CRC had 1.2-fold, and those with localized and regional CRCs had sixfold and fivefold increased risk of PC, respectively.



This study suggests that CRC survivors have an increased risk of developing subsequent PC within 1-5 years. CRC survivors age >50 with localized/regional stage, and right-sided CRC have higher predisposition to PC.
Division of Gastroenterology, Hepatology, and Nutrition, University of Texas Medical School at Houston, 6431 Fannin, MSB 4.234, Houston, TX, 77030, USA.
Erik
E
Rahimi
Division of Gastroenterology, Hepatology, and Nutrition, University of Texas Medical School at Houston, 6431 Fannin, MSB 4.234, Houston, TX, 77030, USA.
Sachin
S
Batra
Division of Gastroenterology, Hepatology, and Nutrition, University of Texas Medical School at Houston, 6431 Fannin, MSB 4.234, Houston, TX, 77030, USA.
Nirav
N
Thosani
Section of Gastroenterology, University of Manitoba and CancerCare Manitoba, 805-715 McDermot Avenue, Winnipeg, MB, R3E3P4, Canada. Harminder.Singh@umanitoba.ca.
Harminder
H
Singh
Division of Gastroenterology, Hepatology, and Nutrition, University of Texas Medical School at Houston, 6431 Fannin, MSB 4.234, Houston, TX, 77030, USA. Sushovan.Guha@uth.tmc.edu.
Sushovan
S
Guha
D000328:Adult; D000368:Aged; D015179:Colorectal Neoplasms / Q000150:complications* / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000453:epidemiology / Q000556:secondary*; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D055815:Young Adult
Colon cancer; Pancreatic cancer; Risk factors; Second primary; Sporadic